On The Pen: The Weekly Dose 5.21.24

Поділитися
Вставка
  • Опубліковано 19 тра 2024
  • Send us a Text Message. (www.buzzsprout.com/twilio/tex...)
    📧 SIGN UP FOR EMAILS: www.onthepen.com/emails
    💳 BECOME A MEMBER: Join this channel
    / @manonthemounjaro
    📰 SEEKING ALPHA ARTICLE: seekingalpha.com/news/4092598...
    🎙️PODCAST LINK: podcasts.apple.com/us/podcast...
    💵 DONATIONS:
    Venmo: venmo.com/u/OnThePen
    Ca$h App: cash.app/$ManOnMounjaro
    PayPal: www.paypal.me/DavidTKnapp
    SOCIAL LINKS
    / manonthemounjaro
    / manonmounjaro
    / manonthemounjaro
    / manonthemounjaro
    📲 Contact Me: MounjaroMan@gmail.com
    👉 Link to other GLP-1 MUST HAVE products I mention: www.amazon.com/shop/manonthem...
    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    • On The Pen: Live
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    • Mounjaro Weight Loss J...
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    • New Weight Loss Meds
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    • GLP-1 News
    SHOW LINKS:
    Novo Nordisk fire:
    Link: www.wsj.com/livecoverage/stoc...
    New CagriSema drug trial
    Link: clinicaltrials.gov/study/NCT0...
    Wegovy Heart Benefits:
    Link: www.cnn.com/2024/05/13/health...
    CT-488 Phase 1 Results:
    Link: www.fiercebiotech.com/biotech...
    Support the Show. (www.buzzsprout.com/2302090/su...)
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    / @manonthemounjaro
    SOCIAL LINKS
    / manonthemounjaro
    / manonmounjaro
    / manonthemounjaro
    / manonthemounjaro
    📲 Contact Me: MounjaroMan@gmail.com
    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    • On The Pen: Live
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    • Mounjaro Weight Loss J...
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    • New Weight Loss Meds
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    • GLP-1 News
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

КОМЕНТАРІ • 10

  • @cloakster
    @cloakster Місяць тому +3

    Nice ‘cast. And tip of the hat to Clark on hunting down that conference info. 🎩
    Lilly didn’t actually say much of anything new about Reta and Orforglipron, but the cool thing is they collected most of the comprehensive Phase 2 results data for each, and put it all into one presentation PDF for each (instead of it all being piecemeal).
    Hadn’t seen the graph on increased heart-rate/tachycardia w/Reta before now though, and it’s a little worrisome.
    We knew about the issues with Reta allegedly causing moderate heart arrhythmias at high doses, but +10 beats per minute too at the top dose? 😯
    Yes, it does fall some over time, but not that much… still +6 bpm at 48 weeks. I know all GLP-1s cause mild and usually transitory heart rate increases, but this seems excessive.
    Lilly *really* needs to get their arms around this, likely via a gentler titration schedule and maybe reducing the top dosage. They’ve apparently *already* slowed the titration in Phase 3… for 12mg, it’s now 2/4/6/9/12, whereas in the Phase 2 it was 2/4/8/12.
    Hopefully that helps, but dunno if it’ll be enough by itself.
    On Orforglipron: Are peptide orals really going to be easier to manufacture than Orforglipron, when you need such a crazy amount of API for them?
    Recall that 50mg Rybelsus doesn’t need just 20 times more semaglutide than 2.4mg Wegovy, but about *150 times more,* since Rybelsus is daily, not weekly like Wegovy. 😯
    And Novo’s said that API is the holdup in releasing high-dose (25 and 50mg) Rybelsus. So maybe Lilly’s oral approach isn’t a disadvantage? Guess we’ll see.
    On South Park’s ‘Ozempic special’… it’ll probably be funny, it probably won’t be insightful or helpful. 🤔
    I like the show, but whenever Parker and Stone try to do meaningful social commentary, they tend to faceplant pretty hard. It’s just not what they’re good at, so hopefully they don’t even try. 🤷‍♂️
    Oh, and sry ‘bout your flooded studio again, Dave. You’re sure having a bad run of luck lately. 😕

  • @djbosnick1072
    @djbosnick1072 Місяць тому +2

    Thanks!

  • @clarkkent7973
    @clarkkent7973 Місяць тому +3

    Awesome podcast! How is there so much news in one week? I am looking forward to the "Dave reacts to South Park: End of Obesity" video

    • @SueUTube
      @SueUTube Місяць тому +1

      Yes. There was a ton of news this week.
      I don't think I'm ready for svelte Cartman.

  • @sashai8660
    @sashai8660 Місяць тому +1

    Thanks Dave.

  • @djbosnick1072
    @djbosnick1072 Місяць тому +1

    Are the people that you've heard of who get their Zepbound approved through Medicare, or is it only Wegovy. I started on Zep, but i'm on compounded tirz at present due not only shortages, also expense because my aetna ins doesn't cover. On 7/1 I'll move over to Medicare. Since I have stroke history, I wonder if I have any hope of getting Zep on Medicare or if it is going to have to be wegovy that I try to get my doc to push approval for.

    • @cloakster
      @cloakster Місяць тому

      Pretty sure Tirzepatide/Zepbound doesn’t have an FDA indication for CVD issues yet (though it is in clinical trials for such, IIRC)… so you’re probably looking at Wegovy, at least for now.
      And yeah, sucks that Medicare won’t cover GLP-1s for obesity.

  • @kathytodd983
    @kathytodd983 Місяць тому

    Best telehealth for compound? Thx!